Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Fredun Pharmaceuticals Ltd. lags significantly behind its peers in key financial metrics such as revenue growth, profitability, and efficiency. While it has no debt, its lack of growth and profitability highlights it as a potential underperformer in the sector. In contrast, companies like Mankind Pharma and Dr. Reddy's Laboratories showcase strong growth and profitability, making them sector leaders.
Highest revenue growth (YoY: 18.12%) and strong profitability (ROE: 23.15%)
Consistently strong profitability (ROE: 21.76%) and reasonable valuation metrics (PE: 15.50)